Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 283

1.

Ex vivo evaluation of prolidase loaded chitosan nanoparticles for the enzyme replacement therapy.

Colonna C, Conti B, Perugini P, Pavanetto F, Modena T, Dorati R, Iadarola P, Genta I.

Eur J Pharm Biopharm. 2008 Sep;70(1):58-65. doi: 10.1016/j.ejpb.2008.04.014. Epub 2008 Apr 27.

PMID:
18547793
2.

Site-directed PEGylation as successful approach to improve the enzyme replacement in the case of prolidase.

Colonna C, Conti B, Perugini P, Pavanetto F, Modena T, Dorati R, Iadarola P, Genta I.

Int J Pharm. 2008 Jun 24;358(1-2):230-7. doi: 10.1016/j.ijpharm.2008.03.012. Epub 2008 Mar 21.

PMID:
18455892
3.

Chitosan glutamate nanoparticles for protein delivery: development and effect on prolidase stability.

Colonna C, Conti B, Perugini P, Pavanetto F, Modena T, Dorati R, Genta I.

J Microencapsul. 2007 Sep;24(6):553-64.

PMID:
17654175
4.

Intracellular delivery of liposome-encapsulated prolidase in cultured fibroblasts from prolidase-deficient patients.

Perugini P, Hassan K, Genta I, Modena T, Pavanetto F, Cetta G, Zanone C, Iadarola P, Asti A, Conti B.

J Control Release. 2005 Jan 20;102(1):181-90.

PMID:
15653144
5.

Biodegradable microspheres for prolidase delivery to human cultured fibroblasts.

Lupi A, Perugini P, Genta I, Modena T, Conti B, Casado B, Cetta G, Pavanetto F, Iadarola P.

J Pharm Pharmacol. 2004 May;56(5):597-603.

PMID:
15142336
6.

Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.

Oyarzun-Ampuero FA, Brea J, Loza MI, Torres D, Alonso MJ.

Int J Pharm. 2009 Nov 3;381(2):122-9. doi: 10.1016/j.ijpharm.2009.04.009. Epub 2009 Apr 15.

PMID:
19467809
7.

Alginate/chitosan nanoparticles are effective for oral insulin delivery.

Sarmento B, Ribeiro A, Veiga F, Sampaio P, Neufeld R, Ferreira D.

Pharm Res. 2007 Dec;24(12):2198-206. Epub 2007 Jun 19.

PMID:
17577641
8.

Thymopentin-loaded pH-sensitive chitosan nanoparticles for oral administration: preparation, characterization, and pharmacodynamics.

Zheng AP, Wang JC, Lu WL, Zhang X, Zhang H, Wang XQ, Zhang Q.

J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):2936-44.

PMID:
17048501
9.

Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.

Sayin B, Somavarapu S, Li XW, Thanou M, Sesardic D, Alpar HO, Senel S.

Int J Pharm. 2008 Nov 3;363(1-2):139-48. doi: 10.1016/j.ijpharm.2008.06.029. Epub 2008 Jul 9.

PMID:
18662762
10.

Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.

Hafner A, Lovrić J, Voinovich D, Filipović-Grcić J.

Int J Pharm. 2009 Nov 3;381(2):205-13. doi: 10.1016/j.ijpharm.2009.07.001. Epub 2009 Jul 9.

PMID:
19596430
11.

Enzyme loaded biodegradable microspheres in vitro ex vivo evaluation.

Genta I, Perugini P, Pavanetto F, Maculotti K, Modena T, Casado B, Lupi A, Iadarola P, Conti B.

J Control Release. 2001 Dec 13;77(3):287-95.

PMID:
11733096
12.

Enhanced antibacterial effect of ceftriaxone sodium-loaded chitosan nanoparticles against intracellular Salmonella typhimurium.

Zaki NM, Hafez MM.

AAPS PharmSciTech. 2012 Jun;13(2):411-21. doi: 10.1208/s12249-012-9758-7. Epub 2012 Feb 23.

13.

Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex.

Cafaggi S, Russo E, Stefani R, Leardi R, Caviglioli G, Parodi B, Bignardi G, De Totero D, Aiello C, Viale M.

J Control Release. 2007 Aug 16;121(1-2):110-23. Epub 2007 Jun 12.

PMID:
17601625
14.

Characterization of folate-chitosan-DNA nanoparticles for gene therapy.

Mansouri S, Cuie Y, Winnik F, Shi Q, Lavigne P, Benderdour M, Beaumont E, Fernandes JC.

Biomaterials. 2006 Mar;27(9):2060-5. Epub 2005 Oct 3.

PMID:
16202449
15.

Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.

Amidi M, Romeijn SG, Borchard G, Junginger HE, Hennink WE, Jiskoot W.

J Control Release. 2006 Mar 10;111(1-2):107-16. Epub 2005 Dec 27.

PMID:
16380189
16.

Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro.

Grenha A, Grainger CI, Dailey LA, Seijo B, Martin GP, Remuñán-López C, Forbes B.

Eur J Pharm Sci. 2007 Jun;31(2):73-84. Epub 2007 Feb 25.

PMID:
17408932
17.

Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.

Zhang J, Chen XG, Li YY, Liu CS.

Nanomedicine. 2007 Dec;3(4):258-65. Epub 2007 Oct 24.

PMID:
17962086
18.
20.

[Chitosan nanoparticles as gene vector: effect of particle size on transfection efficiency].

Yang XR, Zong L, Yuan XY.

Yao Xue Xue Bao. 2007 Jul;42(7):774-9. Chinese.

PMID:
17882964

Supplemental Content

Support Center